Because you changed the concentration
GLP-1 medications address both simultaneously
It is a subcutaneous injection on a provider-determined schedule
By partnering with Eden, staying consistent with dosing, and embracing healthy lifestyle habits, you can unlock the transformative potential of Wegovy and embark on a path to a brighter, healthier future
June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
Youll receive a new shipment each month and have access to their team for questions or dosage adjustments as needed